tiprankstipranks
Trending News
More News >
PHARMABEES
Nippon India Nifty Pharma ETF Units Exchange Traded Fund
Advertisement

IN:PHARMABEES ETF Technical Analysis

Compare

Summary of all the Indicators

Summary
Sell
6Bullish
5Neutral
8Bearish
Oscillators
Buy
3Bullish
5Neutral
1Bearish
Moving Averages
Sell
3Bullish
0Neutral
7Bearish
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) Moving Averages Convergence Divergence (MACD) indicator is 0.17, suggesting Nippon India Nifty Pharma ETF Units Exchange Traded Fund is a Buy.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 20-Day exponential moving average is 23.40, making it a Sell.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 50-Day exponential moving average is 23.19, making it a Sell.

Nippon India Nifty Pharma ETF Units Exchange Traded Fund (PHARMABEES) Pivot Points

Mar 19, 2026, 06:26 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
22.63
23.00
23.20
23.57
23.77
24.14
24.34
Fibonacci
23.00
23.21
23.35
23.57
23.78
23.92
24.14

Nippon India Nifty Pharma ETF Units Exchange Traded Fund (PHARMABEES) Moving Averages

Mar 19, 2026, 06:26 PM
Period
Simple
Exponential
MA5
23.66Sell
23.49Sell
MA10
23.58Sell
23.52Sell
MA20
23.41Sell
23.40Sell
MA50
23.06Buy
23.19Sell
MA100
23.11Buy
23.11Buy
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 10-Day exponential moving average is 23.52, making it a Sell.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 100-Day exponential moving average is 23.11, making it a Buy.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 50-day simple moving average is 23.06, creating a Buy signal.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 100-day simple moving average is 23.11, creating a Buy signal.

Nippon India Nifty Pharma ETF Units Exchange Traded Fund (PHARMABEES) Technical Analysis

Mar 19, 2026, 06:26 PM
Name
Value
Action
RSI (14)
46.25
Neutral
STOCH (9,6)
52.35
Neutral
STOCHRSI (14)
52.35
Neutral
MACD (12,26)
0.17
Buy
ADX (14)
19.56
Buy
Williams %R
-71.14
Buy
CCI (14)
-27.96
Neutral
ATR (14)
0.57
-
Ultimate Oscillator
61.41
Neutral
ROC
0.00
-
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) Relative Strength Index (RSI) is 46.25, creating a Neutral signal.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) Trend Strength Indicator (ADX) is 19.56, creating a Buy signal.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) Commodity Channel Index (CCI) is -27.96, creating a Neutral signal.

FAQ

Is PHARMABEES a Buy, Hold, or Sell?
Based on PHARMABEES’s technical indicators, PHARMABEES is a Sell.
    What is PHARMABEES’s RSI (14)?
    PHARMABEES’s RSI (14) is 46.25, which suggests PHARMABEES is a Neutral.
      What is PHARMABEES’s MACD?
      PHARMABEES’s MACD is 0.17, which suggests PHARMABEES is a Buy.
        What is PHARMABEES’s 5-day moving average?
        PHARMABEES’s 5-day moving average is 23.66, which suggests PHARMABEES is a Sell.
          What is PHARMABEES’s 20-day moving average?
          PHARMABEES 20-day moving average is 23.41, which suggests PHARMABEES is a Sell.
            What is PHARMABEES’s 50-day moving average?
            PHARMABEES’s 50-day moving average is 23.06, which suggests PHARMABEES is a Buy.
              What is PHARMABEES’s 200-day moving average?
              Currently, no data Available
              What is PHARMABEES’s Williams % R (14)?
              PHARMABEES’s Williams % R (14) is -71.14, which suggests PHARMABEES is a Buy.
                What is PHARMABEES’s CCI (14)?
                PHARMABEES’s CCI (14) is -27.96, which suggests PHARMABEES is a Neutral.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis
                  Advertisement